Dr. Daniel Isser Goldman, MD

Dr. Goldman practices at Coastal Eye Associates in Pasadena, Texas.

Dr. Goldman's NPI, 1255335055, was assigned on June 9, 2005. Dr. Goldman graduated from WashU Medicine in 1976. Dr. Goldman holds Texas license G0716.

Dr. Goldman's primary practice is Coastal Eye Associates, at 3333 Bayshore Ave, Pasadena, TX 77504 in Harris County. The practice phone is (281) 488-7213.

Dr. Goldman's primary practice is Coastal Eye Associates in Pasadena, Texas. Dmand AI also links Dr. Goldman to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldman practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Goldman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Goldman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Goldman's licenses on file in 2 states: Texas and California.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, glaucoma and inflammation of iris among the conditions Dr. Goldman treats.

CMS data shows 1,524 Medicare services from Dr. Goldman across 10 procedure codes in 2024, for 210 Medicare patients. Medicare paid $292,954 for them. Every service was in an office.

CMS counts 210 Medicare patients who saw Dr. Goldman in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goldman's median patient age at 74, with 55% women.

In 2024, Dr. Goldman wrote 1,076 Medicare Part D claims for 277 patients. 60% of them were for generic drugs. CMS names the drug for 980 of them, across 18 drugs with 11 or more claims each, at $106,609 in total drug cost. In 2023, CMS named 1,043 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Goldman for performance year 2024, reported as part of a group. Dr. Goldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 42 papers to Dr. Goldman, published from 2001 to 2023. 2010 was the busiest year, with 3. The most frequent topics are Biomechanical Phenomena, Locomotion and Models, Biological. Dr. Goldman has published most often in Phys Rev E Stat Nonlin Soft Matter Phys. Dr. Goldman's most frequent co-author is Kathleen R. Bates, MD.

CMS Open Payments shows 65 general payments to Dr. Goldman from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $915.

Dr. Goldman graduated from WashU Medicine in 1976.

Dr. Goldman is in network with 22 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.